News Highlights: Top Company News of the Day
21 April 2021 - 8:15PM
Dow Jones News
Automation Software Maker UiPath Rises in Market Debut
The company's initial public offering raised about $1.3 billion,
with trading in its shares valuing the business at more than $35
billion.
Hertz Proposes Shareholder Payout as Part of Bankruptcy-Exit Plan
Hertz Global Holdings said an improved bankruptcy plan would
provide some value to equity holders, vindicating the individual
traders who have insisted the company is worth something despite
its bankruptcy filing.
Pfizer Identifies Fake Covid Shots Abroad as Criminals Exploit Vaccine Demand
In Mexico, about 80 people received fraudulent doses, and in
Poland authorities recovered vials containing anti-wrinkle
drugs.
FDA Finds Poor Conditions at Contractor's Plant Making J&J Vaccine
Inspectors found that the Emergent BioSolutions plant that was
helping make Johnson & Johnson's Covid-19 shot didn't maintain
clean and sanitary conditions and didn't follow procedures to
prevent contamination.
European, U.K. Company Earnings Previews
Read what analysts are saying ahead of earnings due Thursday
from Pernod Ricard, Informa, Rentokil and more.
Europe's Most Valuable Tech Company Can Help the Chip Shortage
ASML is an expensive stock, but but it is in part an expression
of the confidence in the company's ability to help fix the great
chip shortage.
Verizon earnings and revenue rise, top expectations
Verizon Communications Inc. topped earnings and revenue
expectations Wednesday while detailing how its recent commitments
for wireless spectrum will impact its financials.
Researchers Uncover Advertising Scam Targeting Streaming-TV Apps
Fraudsters infected nearly one million mobile devices with
software that mimicked streaming-TV apps and collected revenue from
unsuspecting advertisers, according to a cybersecurity company.
Fatal Crash Has Negative ESG Implications for Tesla - ESG Insight
The latest incident puts the electric-vehicle maker's Autopilot
feature and its product quality and safety in the spotlight.
Biotech Stocks Fall Out of Favor After Disappointing Trial Results, Big Rally
Biotech shares have plummeted over the past two months, stung by
setbacks in clinical trials and a rotation away from growth
stocks.
(END) Dow Jones Newswires
April 21, 2021 15:00 ET (19:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.